title: Investigations of antithrombin III-activity in patients after myocardial infarction and a long-term coumarin therapy.
abstract: In 40 M.I. patients with long-term anticoagulant treatment, (Falithrom), the AT III-activity was determined at an interval of three years by means of Chromozym TH. We have found a mean AT III-value in the first testing period of 79.67 (+/- 14.16) per cent and in the second assessment of 82.5 (+/- 10.42) per cent. The difference is not significant. However, we were unable to confirm the comparatively marked increase AT III for dicoumarol treatment found by Roka and Bleyl. In acute M.I.-patients was demonstrated a decreased AT III-activity in the first 3-4 days and a normalisation tendency in the next 10-14 days. Our values of the mean AT III-activity were in the lower normal range for patients with long-term coumarin therapy. In dead patients (average age 70 years) there is a trend of a risk to an untimely death in the presence of pathologic AT III-activity (despite a good anticoagulation of an individual mean quick test from greater than or equal to 0.20 to less than or equal to 0.30) or a bad anticoagulation (mean individual quick tests greater than or equal to 0.30 to 0.35), but a normal AT III-activity. The three dimensional analysis was not significant.
authors: Department of Coagulation Physiology, Municipal Hospital Berlin-Friedrichshain.
authors: L
authors: L
authors: Kühnel
authors: M
authors: M
authors: Karge
authors: C
authors: C
authors: Heinrichs
authors: V
authors: V
authors: Stigge
mesh_terms: D000368:Aged; D000990:Antithrombin III / Q000378:metabolism*; D003374:Coumarins / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood* / Q000188:drug therapy; D013997:Time Factors
chemical_list: D003374:Coumarins; D000990:Antithrombin III; C030123:coumarin